000 | 01542 a2200457 4500 | ||
---|---|---|---|
005 | 20250513055901.0 | ||
264 | 0 | _c19940908 | |
008 | 199409s 0 0 eng d | ||
022 | _a0004-4172 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLao, B | |
245 | 0 | 0 |
_aAlcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives. _h[electronic resource] |
260 |
_bArzneimittel-Forschung _cJun 1994 |
||
300 |
_a727-34 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetaldehyde _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBlood Gas Analysis |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aBody Temperature Regulation _xdrug effects |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDiabetic Angiopathies _xphysiopathology |
650 | 0 | 4 |
_aEthanol _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFlushing _xchemically induced |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
650 | 0 | 4 |
_aLactates _xblood |
650 | 0 | 4 | _aLactic Acid |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPyruvates _xblood |
650 | 0 | 4 | _aPyruvic Acid |
650 | 0 | 4 |
_aSulfonylurea Compounds _xadverse effects |
700 | 1 | _aCzyzyk, A | |
700 | 1 | _aSzutowski, M | |
700 | 1 | _aSzczepanik, Z | |
773 | 0 |
_tArzneimittel-Forschung _gvol. 44 _gno. 6 _gp. 727-34 |
|
999 |
_c8053298 _d8053298 |